Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Elos Medtech acquires Klingel Medical through a guaranteed rights issue

Creating a leading European MedTech CDMO with the combination of Elos Medtech and Klingel Elos Medtech AB (publ) (“Elos Medtech”), a leading development and manufacturing partner for medical devices, today entered into an agreement to acquire Klingel Holding GmbH (“Klingel Medical Group” or “Klingel”) from IK Partners and management. Klingel, a leading contract development and manufacturing organization (CDMO) headquartered in Germany, will strengthen Elos Medtech’s position with extraordinary R&D capabilities and new technology expertise. Further, the acquisition will broaden the

Invitation to a Press Conference on Bittium Corporation’s Half-Year Financial Report January-June 2023

Bittium CorporationPress Release Invitation to a Press Conference on Bittium Corporation’s Half-Year Financial Report January-June 2023 Bittium Corporation, Press Release, July 28, 2023, at 10:00 am (CEST+1) Bittium Corporation’s Half-Year Financial Report January-June 2023 will be published on Friday, August 4, 2023, at 8.00 am (CEST+1). The release will be available on company’s website www.bittium.com immediately after the publication. Bittium will hold a webcast for media, analysts and institutional investors on Friday, August 4, 2023, at 9.00 am (CEST+1). The webcast will

Sotkamo Silver Half-Year Financial Report Q2/2023: Improved profitability by enhanced operational efficiency and higher silver grade

Sotkamo Silver AB, Half-Year Financial Report, 28 July 2023 at 9.45 (EEST) / 08.45 (CET) Sotkamo Silver Half-Year Financial Report Q2/2023: Improved profitability by enhanced operational efficiency and higher silver grade   HIGHLIGHTS April – June (Q2) · Net sales increased by 33 % to 120 MSEK (90 MSEK), driven mainly by a higher average silver grade and positive development of silver price · EBITDA increased by 721 % to 53 MSEK (6), EBITDA margin increased to 44 % (7) · EBIT increased to 34 MSEK (-16) · Profitability increased significantly driven by a higher

Deutsche Börse AG extends offer period for a second time

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR TO ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION.With reference to SimCorp A/S' (SimCorp or the Company) announcement of 25 May 2023 (no. 11/2023) regarding the publication of the offer document (the Offer Document) concerning the all-cash voluntary recommended public takeover offer to acquire all of the issued and outstanding shares (except treasury shares) in SimCorp made by Deutsche Börse AG (Deutsche Börse) and SimCorp's announcement of 7

Symrise announces the outcome of the mandatory public offer to the shareholders of Swedencare

The Offer is not being made, and this press release may not be distributed, directly or indirectly, in or into, nor will any tender of shares be accepted from or on behalf of shareholders in, any jurisdiction in which the making of the Offer, the distribution of this press release or the acceptance of the Offer would contravene applicable laws or regulations or require further registration documents, filings or other measures in addition to those required under Swedish law. Press release28 July 2023On 5 June 2023, Symrise AG (“Symrise”) announced a mandatory public offer to the

Esmaeilzadeh Holding publishes interim report for the first half-year of 2023

“During the second quarter, we have continued to work methodically on our and our portfolio companies' prioritised issues. As a result, several of the portfolio companies have successfully raised capital, which is of great importance for their development plans. Although the acquisition rate has generally been lower in our Operational Groups, we have still been able to add a number of promising companies to these groups.” - Saeid Esmaeilzadeh, Chief Executive Officer Financial overview · Total net asset value was MSEK 7,893 (7,654), equivalent to SEK 10,240 per share (10,097). ·

Alexion enters gene therapy agreement with Pfizer

28 July 2023 Alexion, AstraZeneca Rare Disease, enters agreement with Pfizer to acquire a portfolio of preclinical rare disease gene therapies Agreement furthers Alexion's ambition to transform patient outcomes with genomic medicine and provides synergistic opportunities across AstraZeneca Portfolio includes preclinical gene therapy programmes and enabling technologies with potential across several therapeutic areas Alexion, AstraZeneca Rare Disease, today announced that it has entered a definitive purchase and licence agreement for a portfolio of preclinical gene therapy

A drop in the nickel sulphate market in China decreased Terrafame's operating result while basic production remained at a good level

The financial information presented about Terrafame Ltd in this release consists of unaudited FAS figures. The figures in brackets refer to the corresponding period of the previous year unless otherwise stated. April−June 2023 in brief: · Net sales from the battery chemicals business operations decreased to EUR 32.1 (53.4) million, or around 35% of the company’s total net sales. The decline was due to a significant drop in the nickel sulphate market in China, which resulted in Terrafame's decision to stop production at its battery chemicals plant in June–July. · Net sales from

Optomed’s January-June 2023 half year report will be published on 4 August 2023

Optomed Plc Press Release 28 July 2023 at 9.00, Helsinki Optomed’s January-June 2023 half year report will be published on 4 August 2023 Optomed will publish its January-June 2023 half year report on 4 August 2023 approximately at 9.00 EEST.   A telephone conference for analysts, investors and media will be arranged on the publishing day at 11.00 EEST/10.00 CET. The event will be held in English. The presentation material will be available at www.optomed.com/investors 10.00 EEST at the latest.   The participants are requested to register for the call in advance by email to

Final Results for the year to 31 January 2023

28 July 2023 LIMITLESS EARTH PLC ("Limitless" or the "Company") Final Results for the year to 31 January 2023 The Company announces its final results for the year to 31 January 2023. The Annual Report and Accounts for the year ended 31 January 2023 will shortly be posted to shareholders and uploaded to the Company’s website: www.limitlessearthplc.com. This announcement contains inside information for the purposes of UK Market Abuse Regulation. The Directors of the Company take responsibility for this announcement. For further information, please contact: Limitless

interim report 2023, January to June

17 percent net operating income growth, like-for-likeRental income was EUR 163 million,an increase of 16.8 percent compared to the same period last year.4.7 percentage points are related to changes in the property portfolio.The like-for-like rental income growth was 12.1 percent,due to growth in new lease levels and higher occupancy level.The like-for-like vacancy rate decreased by 2.9 percentage points during the last twelve months,mainly as a result of finished capital projects and strong demand for apartments.Vacancy rate at the end of the quarter was 6.9 percent where 84

Hoist Finance interim report Q2 2023

”The second quarter was a strong quarter for Hoist Finance. We more than doubled our adjusted earnings before tax and we are closing in on our RoE target of 15 per cent. At the same time we continue to address our cost base with the last push of the rejuvenation programme. With the lowest funding costs in the industry, a competitive business model and a robust capital base we are well equipped to seize the opportunities that the market and a reshaping industry provides”, says Harry Vranjes, CEO at Hoist Finance. Key highlights · Profit before tax amounted to SEK 178m and adjusted

Continued strong growth – EBITDA increased by 46 percent

SECOND QUARTER APRIL–JUNE            · The Group’s net sales amounted to SEK 386.1 (284.1) million, an increase of 36 percent. · The Group’s EBITDA was SEK 86.6 (59.4) million, an increase of 46 percent. · The EBITDA margin was 22 (21) percent. · Profit after tax amounted to SEK 46.8 (21.1) million. · Earnings per share amounted to SEK 3.2 (1.4). · Cash flow from operating activities was SEK 39.7 (24.4) million. HALF-YEAR JANUARY–JUNE · The Group’s net sales amounted to SEK 766.3 (546.9) million, an increase of 40 percent. · The Group’s EBITDA was SEK 146.0 (

BPEA EQT to acquire a majority stake in Indira IVF – India’s largest chain of fertility clinics

· BPEA EQT to acquire a majority stake in Indira IVF, the largest provider of fertility services in India and top five globally in terms of annual IVF cycles, having facilitated 125,000 successful pregnancies to date · India is one of the fastest growing markets globally for Assisted Reproductive Technology  services due to its large addressable population, rising education levels and marriage age, declining fertility rates, and low market penetration  · BPEA EQT will invest in Indira IVF’s R&D capabilities and technology, while further broadening its footprint across India and

Lundin Mining Announces Closing of $800 Million Term Loan with Additional $400 Million Accordion Available

TORONTO, July 27, 2023 /CNW/ - (TSX: LUN; Nasdaq Stockholm: LUMI) Lundin Mining Corporation (“Lundin Mining” or the “Company”) is pleased to announce the closing of a three-year term loan (“Term Loan”) in a principal amount of $800 million, with an additional $400 million accordion becoming available upon receipt of additional binding commitments and closing of up to an additional nineteen (19%) interest in SCM Minera Lumina Copper Chile (“Lumina Copper”) and satisfaction of relevant conditions precedent.  The Company has used the Term Loan to refinance the drawdown under the existing

DanCann Pharma A/S Completes Issuance of New Shares from Debt Conversion under the 10-Year Financing Loan-Agreement with 12-months Conversion Option with Nordic Growth Opportunities 2

COPENHAGEN, Denmark, 27 July 2023 – DanCann Pharma A/S (SS: DANCAN) (OTCQB: DCPXF) ("DanCann Pharma" or the "Company"), a Danish company powered by cannabinoids, has today, on 27 July 2023, issued a total of 2,213,437 new shares of nominally DKK 0.0375 each by conversion of debt in the total amount of DKK 500,000 under the instrument issued as of 13 July 2023.As set out in press release published on 17 July 2023, the Company has issued a total of 378 convertible debt instruments, each of an amount of DKK 50,000, equal to an aggregate amount of DKK 18,900,000, and 8,190,000 warrants to

Capital increase in Impero A/S in connection with exercise of warrants

Company Announcement No. 9-2023 Copenhagen, 27 July 2023 Impero A/S announces today that Impero A/S’ share capital is increased by nominally DKK 1,000 as a result of exercise of warrants issued under the company’s warrant program. The capital increase is effected without pre-emptive rights for Impero A/S’ existing shareholders or others. The shares are subscribed in cash at a subscription price of DKK 3.30 per share of nominally DKK 0.10. The total proceeds for Impero A/S amount to DKK 33,000. The new shares correspond to approximately 0.05% of Impero A/S’ share capital prior

Nordea Bank Abp: Repurchase of own shares on 27.07.2023

Nordea Bank AbpStock exchange release – Changes in company’s own shares27.07.2023 at 22.30 EET Nordea Bank Abp (LEI: 529900ODI3047E2LIV03) has on 27.07.2023 completed repurchases of own shares (ISIN: FI4000297767) as follows: +----------+-------+-------------------+-------------------+| Trading |Number | Weighted average |Total cost, EUR* **||venue (MIC| of |price / share, EUR*| || Code) |shares | ** | |+----------+-------+-------------------+-------------------+|XHEL |74,583 |10.31 |768,943.27

ABS Approves Pioneering Ammonia-based Ship HVAC Refrigeration System from HD Hyundai Heavy Industries

(ULSAN, KOREA) ABS issued approval in principle to HD Hyundai Heavy Industries (HHI) for its new ammonia-based ship HVAC refrigeration system. HHI developed the system in response to shipowners’ requests for refrigeration of HVAC systems using ammonia, a more eco-friendly refrigerant with a zero ozone depletion potential (ODP) and a Global Warming Potential of zero per the American Society of Heating, Refrigerating and Air-Conditioning Engineers, Inc. (ASHRAE). ABS used its marine vessel rules to conduct technical suitability reviews of the designs, materials, fire and

The Best Candle Scents For Each Room In The Home

When it comes to ensuring your home feels comfortable and welcoming, scent is an important aspect. Scents help to add character and depth to your space, and it allows you to create a different ambience in each room.    [A group of candles in glasses Description automatically generated]   Interior design expert Ryan McDonough at MyJobQuote.co.uk  has created this list of the best candle scents for each room of the home. If you’re looking to create the best feeling in each of the rooms of your home, take a look at this list to find out which scent

Bittium Corporation: SHARE REPURCHASE 27.7.2023

Bittium Corporation  ANNOUNCEMENT  27.7.2023 Bittium Corporation: SHARE REPURCHASE 27.7.2023 In the Helsinki Stock Exchange Trade date           27.7.2023Bourse trade         BuyShare                  BITTIAmount             1 900 SharesAverage price/ share    4,1000 EURTotal cost            7 790,00 EUR Bittium Corporation now holds a total of 110 372 sharesincluding the shares repurchased on 27.7.2023 On behalf of Bittium Corporation Nordea Bank Oyj

There are no items matching the current filter
There are no more items matching the current filter
Back to top